City
Epaper

ICMR, NIV to start phase-3 clinical trials of recombinant dengue vax: Centre

By IANS | Updated: May 29, 2024 20:00 IST

New Delhi, May 29 The Indian Council of Medical Research (ICMR) along with the Pune-based National Institute of ...

Open in App

New Delhi, May 29 The Indian Council of Medical Research (ICMR) along with the Pune-based National Institute of Virology (NIV) and other research institutes are set to launch phase-3 clinical trials of the recombinant dengue vaccine, said Apurva Chandra, Union Health Secretary on Wednesday.

He said this while addressing the BRICS (Brazil, Russia, India, China, and South Africa) Health Ministers' Meeting on the sidelines of the 77th World Health Assembly (WHA) of the World Health Organization (WHO) in Geneva.

The Health Secretary said that the BRICS Vaccine Research and Development Centre was virtually launched during India’s presidency in March 2022.

"India has demonstrated active engagement in BRICS health track initiatives, promoting collaborative endeavours to advance joint health agendas aimed at fortifying health systems across BRICS nations, thereby addressing critical global health challenges," Chandra said.

"ICMR along with NIV and a network of other partner Institutes is embarking on phase-3 clinical trials of recombinant dengue vaccine."

"In addition, ICMR and other partners will also work towards research and trials for locally endemic diseases such as Kyasanur Forest Disease (KFD), Nipah virus, Human Papillomavirus, MTBVAC (Mycobacterium Tuberculosis Vaccine), and influenza," he added.

Further, Chandra noted that India's national action plan on AMR, launched in 2017, is in line with the objectives outlined in the WHO's Global Action Plan on Antimicrobial Resistance (AMR).

"India recognises AMR as a global concern and advocates fostering collaboration among BRICS nations to devise and execute protocols, projects, and platforms to tackle AMR," the Union Health Secretary said.

He noted that "India acknowledges the importance of advancing collaboration within BRICS countries in nuclear medicine and radio-pharmaceutical science".

The country also aims to strengthen "the radio-pharmaceutical supply chain and enhance isotopes production, alongside fostering the development and commercialisation of advanced digital solutions," he added.

Chandra urged member states to enhance collaboration and work together to find solutions to various health challenges.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

MaharashtraLonavala Murder Case: Cops Arrest Two For Killing A Woman And Dumping Her Body in Pink Suitcase Near Railway Tracks

Other SportsPremier League: Newcastle Utd move to third place with 2-0 win vs Chelsea

BusinessIndia, EU to kick off next round of free trade talks in Delhi on Monday

EntertainmentTanvi The Great: Karan Tacker to portray armyman in Anupam Kher's directorial

National13 Karnataka students return to New Delhi from Kashmir

Health Realted Stories

HealthJ&K: Jan Aushadhi Kendras bring respite to Baramulla residents with cheaper medicines

HealthExercise special caution, cancel all leaves: Haryana Health Minister

HealthNeed health culture to fight obesity and serve nation: Delhi CM

HealthTraditional medicine key to achieve universal health coverage: Ayush Ministry

HealthLipolysis more effective in women than men: Study